Springer Nature
Browse
13195_2019_567_MOESM1_ESM.pdf (174.29 kB)

MOESM1 of Methylphenidate and galantamine in patients with vascular cognitive impairment–the proof-of-principle study STREAM-VCI

Download (174.29 kB)
journal contribution
posted on 2020-01-08, 04:55 authored by Jolien Leijenaar, Geert Groeneveld, Erica Klaassen, Anna Leeuwis, Philip Scheltens, Henry Weinstein, Joop Gerven, Frederik Barkhof, Wiesje Flier, Niels Prins
Additional file 1: Table S1. Pharmacodynamic Outcomes. Figure S1. Overview of the concentration of methylphenidate (A) and galantamine (B) with colors representing adverse events.

Funding

Alzheimer Nederland

History

Usage metrics

    Alzheimer's Research & Therapy

    Categories

    Keywords

    Vascular cognitive impairmentMethylphenidateGalantamineCognitionVascular dementiaMCI

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC